Combining entacapone with levodopa/DDCI improves clinical status and quality of life in Parkinson’s Disease (PD) patients experiencing wearing-off, regardless of the dosing frequency: results of a large multicentre open-label study

Author: Onofrj M.   Thomas A.   Vingerhoets F.   Martin W.   Giménez-Roldán S.   Azulay J.-P.   Bernhard G.   Schmidt W.   Markabi S.  

Publisher: Springer Publishing Company

ISSN: 0300-9564

Source: Journal of Neural Transmission, Vol.111, Iss.8, 2004-08, pp. : 1053-1063

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content